The failure to detect changes in chemotherapy-induced peripheral neuropathy in adult NMNAT2+/- mice cannot be attributed to compensatory changes in other NMNAT isoforms, NMNAT enzyme activity or changes in MAP2 or neurofilament levels in adult DRG. The gene discussed is MAP2; the disease is peripheral neuropathy.